小细胞肺癌全身18F-FDG PET/CT再分期中的甲状腺转移
本文报道一例65岁女性小细胞肺癌患者,既往有多发甲状腺结节(分类为良性结节性甲状腺肿)。在18F-FDG PET/CT再分期中,这些甲状腺病灶显示FDG摄取增高且病变进展,遂行细针穿刺,于首次肿瘤诊断后14个月证实为小细胞肺癌甲状腺转移。
要点
- 肿瘤患者全身FDG PET/CT中甲状腺偶发病灶常见,部分伴FDG摄取增高。
- 甲状腺转移极罕见,甲状腺病灶是良性甲状腺肿还是需进一步评估常存争议。
- 本例甲状腺病灶FDG摄取增高且进展,细针穿刺证实为小细胞肺癌转移。
核心结论
- 甲状腺病灶在FDG PET/CT再分期中显示摄取增高和进展时,经细针穿刺证实为小细胞肺癌转移。
研究设计与样本
- 本文为病例报告,对象为一名65岁女性小细胞肺癌患者,甲状腺有多发病灶并分类为良性结节性甲状腺肿。
主要发现
- 再分期18F-FDG PET/CT显示甲状腺病灶FDG摄取增高且病变进展。
- 细针穿刺结果证实为小细胞肺癌转移,时间为首次肿瘤诊断后14个月。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Incidental findings of thyroid lesions, some of which show increased FDG uptake, are common in whole-body FDG PET/CT imaging of oncological patients. As metastases to the thyroid are extremely rare, it is often a matter of debate, whether thyroid lesions should be considered as benign goiter or evaluated further. Here, we present the case of a 65-year-old woman with history of small cell lung cancer and multiple thyroid lesions, classified as benign nodular goiter. Because in restating using 18F-FDG PET/CT these lesions showed an increased FDG uptake and growth progression, decision was made for fine-needle aspiration, which revealed small cell lung cancer metastasis 14 months after first tumor diagnosis.
引用
- Vogel J, Tenev A, Solass W, et al. Thyroid Metastasis in Whole-Body 18F-FDG PET/CT Restaging of Small Cell Lung Cancer. Clin Nucl Med. 2022. PMID: 34874354. doi:10.1097/RLU.0000000000003748
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。